N. A. Roberts

1.8k total citations
28 papers, 1.5k citations indexed

About

N. A. Roberts is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, N. A. Roberts has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in N. A. Roberts's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (8 papers) and Biochemical and Molecular Research (5 papers). N. A. Roberts is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (8 papers) and Biochemical and Molecular Research (5 papers). N. A. Roberts collaborates with scholars based in United Kingdom, United States and Switzerland. N. A. Roberts's co-authors include J. Ives, I. B. R. Duncan, Lauren E. Kelly, Rob Lambkin‐Williams, Dirk B. Mendel, Jane Craig, R. Dupree, N. Khosrovani, A.W. Sleight and C. Y. Tai and has published in prestigious journals such as Chemistry of Materials, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

N. A. Roberts

28 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. A. Roberts United Kingdom 16 623 448 332 316 251 28 1.5k
S. Jönsson Iceland 24 463 0.7× 317 0.7× 718 2.2× 487 1.5× 101 0.4× 45 1.8k
Heinrich Hohenberg Germany 17 342 0.5× 177 0.4× 447 1.3× 380 1.2× 94 0.4× 23 1.4k
Yue Huang China 24 240 0.4× 416 0.9× 1.1k 3.3× 791 2.5× 240 1.0× 84 1.9k
Jean Rancourt Canada 21 222 0.4× 289 0.6× 276 0.8× 151 0.5× 139 0.6× 44 1.3k
Jindřich Jindřich Czechia 19 280 0.4× 405 0.9× 351 1.1× 195 0.6× 166 0.7× 64 1.2k
Haiyan Zhao China 22 143 0.2× 316 0.7× 500 1.5× 170 0.5× 318 1.3× 48 1.6k
Bruce Irvine United States 16 1.7k 2.8× 426 1.0× 678 2.0× 261 0.8× 38 0.2× 19 3.0k
Fan Zheng China 25 319 0.5× 321 0.7× 422 1.3× 922 2.9× 160 0.6× 102 1.8k
Wenping He United States 21 354 0.6× 196 0.4× 347 1.0× 59 0.2× 121 0.5× 28 1.5k
Mini Balakrishnan United States 19 202 0.3× 554 1.2× 681 2.1× 772 2.4× 53 0.2× 49 1.3k

Countries citing papers authored by N. A. Roberts

Since Specialization
Citations

This map shows the geographic impact of N. A. Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. A. Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. A. Roberts more than expected).

Fields of papers citing papers by N. A. Roberts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. A. Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. A. Roberts. The network helps show where N. A. Roberts may publish in the future.

Co-authorship network of co-authors of N. A. Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of N. A. Roberts. A scholar is included among the top collaborators of N. A. Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. A. Roberts. N. A. Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melby, Thomas, Prakash Sista, Ralph DeMasi, et al.. (2006). Characterization of Envelope Glycoprotein gp41 Genotype and Phenotypic Susceptibility to Enfuvirtide at Baseline and on Treatment in the Phase III Clinical Trials TORO-1 and TORO-2. AIDS Research and Human Retroviruses. 22(5). 375–385. 57 indexed citations
2.
Herlocher, M. Louise, et al.. (2002). Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. Antiviral Research. 54(2). 99–111. 124 indexed citations
3.
Ives, J., Lauren E. Kelly, Rob Lambkin‐Williams, et al.. (2002). Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Research. 54(2). 79–88. 154 indexed citations
4.
Ives, J., Dirk B. Mendel, C. Y. Tai, et al.. (2002). The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Research. 55(2). 307–317. 300 indexed citations
5.
Smith, Sue, N. A. Roberts, A. Guz, & Teresa D. Tetley. (1996). Compromised inhibition of human lung lavage cell elastases. FEBS Letters. 390(2). 187–190. 4 indexed citations
6.
Roberts, N. A., et al.. (1996). Co‐therapy with Suboptimal Doses of Interleukin‐12 and Interferon‐α Promotes Synergistic Protection against Herpes Virus Infection. Annals of the New York Academy of Sciences. 795(1). 354–356. 2 indexed citations
7.
Khosrovani, N., et al.. (1995). Negative Thermal Expansion and Phase Transitions in the ZrV2-xPxO7 Series. Chemistry of Materials. 7(2). 412–417. 244 indexed citations
8.
Khosrovani, N., et al.. (1995). ChemInform Abstract: Negative Thermal Expansion and Phase Transitions in the ZrV2‐xPxO7 Series.. ChemInform. 26(25). 1 indexed citations
9.
Galpin, S., N. A. Roberts, Tim O’Connor, David Jeffries, & Derek Kinchington. (1994). Antiviral Properties of the HIV-1 Proteinase Inhibitor RO 31-8959. Antiviral chemistry & chemotherapy. 5(1). 43–45. 13 indexed citations
10.
Craig, Jane, Lynne Whittaker, I. B. R. Duncan, & N. A. Roberts. (1994). In vitroanti-HIV and Cytotoxicological Evaluation of the Triple Combination: AZT and ddC with HIV Proteinase Inhibitor Saquinavir (Ro 31-8959). Antiviral chemistry & chemotherapy. 5(6). 380–386. 21 indexed citations
11.
Craig, Jane, Lynne Whittaker, I. B. R. Duncan, & N. A. Roberts. (1993). In vitroResistance to an Inhibitor of HIV Proteinase (Ro 31-8959) Relative to Inhibitors of Reverse Transcriptase (AZT and TIBO). Antiviral chemistry & chemotherapy. 4(6). 335–339. 27 indexed citations
12.
Graves, Bradford, Marcos Hatada, Mary C. Graves, et al.. (1991). The Three-Dimensional X-Ray Crystal Structure of HIV-1 Protease Complexed with a Hydroxyethylene Inhibitor. Advances in experimental medicine and biology. 306. 455–460. 14 indexed citations
13.
PARKES, K. E. B., et al.. (1991). Biological and Biochemical Studies on Ro31-6840 (2′βFddC), a Dideoxynucleoside Analogue Active Against Human Imhunodeficiency Virus Type 1 (HIV-1). Nucleosides and Nucleotides. 10(1-3). 401–404. 5 indexed citations
14.
Craig, Jane, I. B. R. Duncan, D. J. Hockley, et al.. (1991). Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase. Antiviral Research. 16(4). 295–305. 151 indexed citations
15.
Craig, Jane, C. Grief, John Mills, et al.. (1991). Effects of a Specific Inhibitor of HIV Proteinase (Ro 31-8959) on Virus Maturation in a Chronically Infected Promonocytic Cell Line (U1). Antiviral chemistry & chemotherapy. 2(3). 181–186. 23 indexed citations
16.
Duncan, I. B. R., et al.. (1990). Synthesis and antiviral activity of monofluoro and difluoro analogs of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1). Journal of Medicinal Chemistry. 33(8). 2137–2145. 63 indexed citations
17.
Johnson, William H., N. A. Roberts, & Neera Borkakoti. (1987). Collagenase Inhibitors: Their Design and Potential Therapeutic Use. Journal of enzyme inhibition. 2(1). 1–22. 94 indexed citations
18.
Roberts, N. A., et al.. (1986). Histidine analogues as potential novel antirheumatic agents.. PubMed. 1(2). 113–8. 2 indexed citations
19.
Bradshaw, D., C. H. Cashin, Arion Kennedy, & N. A. Roberts. (1984). Pharmacological and biochemical activities of Tenoxicam (Ro 12-0068), a new non-steroidal anti-inflammatory drug. Inflammation Research. 15(5-6). 569–577. 20 indexed citations
20.
Jones, Sarah, Arion Kennedy, & N. A. Roberts. (1982). Assessment of drugs for activity in established type II collagen arthritis. Inflammation Research. 12(5). 650–656. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Jönsson Breakdown of academic impact, for papers by Heinrich Hohenberg Breakdown of academic impact, for papers by Yue Huang Breakdown of academic impact, for papers by Jean Rancourt Breakdown of academic impact, for papers by Jindřich Jindřich Breakdown of academic impact, for papers by Haiyan Zhao Breakdown of academic impact, for papers by Bruce Irvine Breakdown of academic impact, for papers by Fan Zheng Breakdown of academic impact, for papers by Wenping He Breakdown of academic impact, for papers by Mini Balakrishnan
Rankless by CCL
2026